Dear HGVS,
We have discussed how we correctly write the nomenclature for a recurrent CNV identified by whole genome sequencing.
We have e.g. identified the classic 22q11 (LCR22A-LCR22D) deletion in a patient by WGS.
In the HGVS homepage there is the following example:
We are in doubt if we can interpret this as “breakpoint not properly mapped” instead of “breakpoint not sequenced” , because when we perform WGS the breakpoint is sequenced, however due to the LCR regions flanking the recurrent CNV the data are not properly mapped in those regions in the hg38 reference. It is often not possible to identify the exact breakpoint. We therefor think it is a good idea to use the brackets to indicate in the nomenclature that we do not know the exact breakpoints. Would it be correct to write like this:
NC_000022.11:g.(18747401_21224600)del (here we use the breakpoints given by the bioinformatic algorithm that are approximate as we cannot see the breakpoint exactly int the software).
Or would it be better to give an interval for the two breakpoint regions and then write like this:
NC_000022.11:g.(18159723_18924717)_(21111384_21562827)del
We look forward to hear your opinion on this.
Kind regards, Rikke
Rikke Christensen
Clinical Seniorspecialist, PhD
Clinical Laboratory Geneticist (CLG)
Tel. +45 7845 5506
Department of Clinical Genetics
Brendstrupgaardsvej 21C ▪ DK-8200 Aarhus N
